Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
J. Clin. Oncol., Sep;30(25):3148-9 (2012)
The effect of age on delay in diagnosis and stage of breast cancer.
Oncologist., 17(6):775-82 (2012)
Should a sentinel node biopsy be performed in patients with high-risk breast cancer?
Int J Breast Cancer., 2011:973245 (2011)
Breast cancer survivors' perceptions of survivorship care options.
J. Clin. Oncol., Jan;30(2):158-63 (2012)
Adjuvant chemotherapy in luminal breast cancers.
Breast., Oct;20 Suppl 3:S128-31 (2011)
American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities.
J. Clin. Oncol., Oct;29(28):3816-24 (2011)
A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.
Clin. Breast Cancer., Dec;11(6):376-83 (2011)
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
J. Clin. Oncol., Mar;28(7):1145-53 (2010)
The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
Cancer., Jan;117(1):180-9 (2011)
VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.
Clin. Cancer Res., Dec;14(23):7871-7 (2008)
Trends in racial and age disparities in definitive local therapy of early-stage breast cancer.
J. Clin. Oncol., Feb;27(5):713-9 (2009)
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
Clin. Cancer Res., Feb;15(4):1452-9 (2009)
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
Breast Cancer Res. Treat., Oct;117(3):615-23 (2009)
Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors.
Cancer Causes Control., Oct;20(8):1523-8 (2009)
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
Med Care., Jul;47(7):765-73 (2009)
Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women.
Breast Cancer Res. Treat., Jun;121(3):743-51 (2010)
Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer.
Breast., Apr;19(2):69-75 (2010)
Advances in adjuvant endocrine therapy for postmenopausal women.
J. Clin. Oncol., Feb;26(5):798-805 (2008)
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancer.
J. Clin. Oncol., Apr;26(12):1993-9 (2008)
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
J. Natl. Cancer Inst., May;100(9):642-8 (2008)